Home CorTechs Labs

CorTechs Labs

CorTechs Labs Presents Findings on the Creation of Machine Learning Models to Aid Early, Accurate Diagnosis of MS at ACTRIMS 2020

The company will be exhibiting at Americas Committee for Treatment & Research in Multiple Sclerosis’ (ACTRIMS) 2020 annual forum, which is taking place from February 27-29, 2020. In addition to exhibiting LesionQuant’s ability to segment and quantify new, active and resolving lesions as well as gray and white matter on the floor at booth number 412, the company will present their findings from a recent study titled: “Performance Evaluation for Multiple Sclerosis Identification Models Based on MR Imaging and Machine Learning.” The company will also be participating jointly with The Consortium of Multiple Sclerosis Centers and other industry experts, in a presentation titled: “Updated Recommendations for a Standardized MRI Protocol for Multiple Sclerosis.”

CorTechs Labs Enters Phase 2 of $1.15 Million NIH Grant

This project, funded by a $1.15 million, multi-year grant from the National Institutes of Health (NIH), was awarded to CorTechs Labs in December of 2018.